 |
Just Released
|
||
|
COVID-19 Puts Medication Abortion in the Spotlight
A
new post from KFF explores how state responses to limit
abortion access during the COVID-19 pandemic has drawn renewed attention to
the provision of medication abortion using telemedicine approaches. Medication
abortion via telemedicine is a method that can be used to safely provide
women with access to abortion care while social distancing, preserving
personal protective equipment, and limiting risk of exposure to coronavirus.
A
new telemedicine protocol --“no-test” medication abortions-- has been
developed in response to COVID-19. This approach, based on studies conducted
outside the US demonstrating its safety, enables many patients to safely
obtain abortions without needing in-person tests or exams. This approach,
along with other telemedicine protocols, however, would not be available in
many states because of state laws and policies that prohibit its use.
Currently,
in 23 states, providers could adopt this method to offer medication abortion
because there are not laws or policies that prohibit its use. However, in
other states, laws explicitly ban telemedicine abortions or make them
impractical by requiring the prescribing clinician to be physically present with
the patient, ultrasounds before abortions, or in-person counseling.
Filling the need for trusted
information on national health issues, KFF (Kaiser Family Foundation) is a
nonprofit organization based in San Francisco, California.
|
|||
|
|||
|
Connect with us:
    |
|||
|
|||
Monday, June 8, 2020
COVID-19 Puts Medication Abortion in the Spotlight
Subscribe to:
Post Comments (Atom)
This comment has been removed by a blog administrator.
ReplyDelete